The 3rd SAPA-GP Annual Conference Program

Sino-American Pharmaceutical Professionals Association

Greater Philadelphia Chapter (SAPA-GP)

The Third SAPA-GP Annual Conference

Globalization of Pharmaceutical/Biotech R&D

Saturday, June 18, 2005

Science Center, Montgomery County Community College,

340 Dekalb Pike, Blue Bell, Pennsylvania, 19422

Registration, Continental Breakfast and Networking – 7:40 to 8:30 am

Session 1: Current Trends in World Pharmaceutical/Biotech Industry

Han-Cheng Zhang, Ph.D. (8:35 – 8:40 am)

President of SAPA-GP & Conference Chair

Opening Remarks

Keynote Speakers

Anthony Ford-Hutchinson, Ph.D. (8:40 – 9:10 am)

Executive Vice President, Worldwide Basic Research,

Merck Research Laboratories, Merck & Co., Inc.

Current Challenges and Opportunities of Global Drug Discovery

Baruch S. Blumberg, M.D., Ph.D. (9:10 – 9:40 am)

Nobel Prize Laureate in Medicine, Fox Chase Distinguished Scientist,

Senior Advisor to President, Fox Chase Cancer Center

Global Issues and Infectious Disease. The Worldwide Hepatitis B Vaccination Campaign

Jose V. Sartarelli, Ph.D. (9:40 – 10:10 am)

Company Group Chairman, Asia-Pacific/Japan/Latin America,

Johnson & Johnson Pharmaceuticals Group

Prospects for Asia-Pacific and China. A World of Possibilities

Coffee Break (10:10 – 10:25 am)

Lance K. Gordon, Ph.D. (10:25 – 10:55 am)

CEO, VaxGen, Inc.

Current Solutions to the Global Threat of Bioterrorism

Robert R. Ruffolo, Jr., Ph.D. (10:55 – 11:25 am)

President, Research & Development, Wyeth Pharmaceuticals,

Senior Vice President, Wyeth Corporation

Strategies to Integrate Discovery, Development and Global Marketing

SAPA-GP Award and Election Announcements

(11:25 – 11:30 am)

Han-Cheng Zhang, Ph.D. Li Shi, Ph.D.

President, SAPA-GP & Conference Chair President-elect, SAPA-GP & Conference Co-Chair

Lunch Break (11:30 am– 12:30 pm)

(Provided by King Buffet, 610-828-7889)

Session 2: Global R&D Alliance and Outsourcing

(All presentations will be delivered in English)

Chairperson: Li Shi, Ph.D.

Keynote Speakers

Ling Chen, M.D., Ph.D. (12:30 – 12:50 pm)

Director-General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences

An East-West Partnership in Innovative Medicine, Has the Time Arrived?

Ken Fong, Ph.D. (12:50 – 1:10 pm)

Chairman, Kenson Ventures, Founder of Clontech

Biotech and Pharmaceutical Development in China and US - Opportunities and Challenges

George Blumberg, Ph.D. (1:10 – 1:30 pm)

Director, Blumberg Associates Limited, Oxford Centre for Innovation, Oxford, UK

The Growth and Competitiveness of the European Union and its Biotech Industry

Ling Su, Ph.D. (1:30 – 1:50 pm)

Director, Medical and International Pharma Development, Shanghai Roche Pharmaceuticals Ltd.

Global Drug Clinical Development in Asia and China

Kewen Jin, Ph.D. (1:50 – 2:10 pm)

CEO, Shanghai BioExplorer

Pre-clinical Service - A New Area of Offshore R&D Outsourcing

Nathan Xin Zhang, M.D., Ph.D., MBA (2:10 – 2:30 pm)

Chairman and CEO, Sinocro Partners

Investing into Chinese Life Science Industry

Bill Guo, Ph.D. (2:30 – 2:50 pm)

CEO and President, Venturepharm Holdings Ltd.

Opportunities for Outsourcing of Integrated Pharmaceutical Development in China

Coffee Break (2:50 – 3:05 pm)

Session 3: Chinese Biotech/Pharma: Challenges and Opportunities

(Presentations will be delivered in English or Chinese)

Chairperson: Jian Li, Ph.D.

Keynote Speakers

Dequan Ren (3:05 – 3:25 pm)

Deputy Director, China State Food Drug Administration (SFDA)

Recent Development of Drug Regulatory in China

Hongguang Wang, Ph.D. (3:25 – 3:45 pm)

Director-General, China National Center for Biotechnology Development,

The Ministry of Science and Technology of China

Biotechnology and Bioindustry in China

Ming-De Yu (3:45 – 4:05 pm)

Executive Chairman, China Worldbest Life Industry Co.

Executive Chairman, China Pharmaceutical Enterprise Management Association and

China Pharmaceutical Enterprise Directors Association

Current Status and Prospects of Chinese Pharmaceutical Industry

Huacheng Wei, MBA (4:05 – 4:25 pm)

Chairman, Beijing Pharmaceutical Group Co.

Globalization Trends of Chinese Medicine

Jingkang Shen, Ph.D. (4:25 – 4:45 pm)

Deputy Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

`Drug Discovery and Development at Shanghai Institute of Materia Medica`

Ge Li, Ph.D. (4:45 – 5:05 pm)

Chairman and CEO, Wuxi PharmaTech Co., Ltd.

R&D Outsourcing in China

Coffee Break and Snack (5.05 – 5:20 pm)

Jing Cheng, Ph.D. (5:20 – 5:40 pm)

CEO and CTO, CapitalBio Corporation

Start-up Biotech Companies and Global Collaborations in China

Xian-Ping Lu, Ph.D. (5:40 – 6:00 pm)

Co-Founder, Director, and Chief Scientific Officer, Shenzhen Chipscreen Biosciences

Modern Drug Discovery and Development Efforts by Chinese Biopharmaceutical Industry

Ying Luo, Ph.D., MBA (6:00 – 6:20 pm)

President and CEO, Shanghai Genomics, Inc.

How to Balance Between Research Budget and Revenue Growth in Chinese Biotech Start-up

Yongzheng Hui (6:20 – 6:40 pm)

Chairmen and President of Shanghai Innovation Center of Traditional Medicine,

Former Deputy Minister, The Ministry of Science and Technology of China

Globalization Trends in Chinese Pharmaceutical Industry

Panel Discussion (6:40 – 7:20 pm)

Panelists: Speakers from Sessions 2&3

Moderators: Han-Chang Zhang, Ph.D. and Li Shi, Ph.D.

Shanghai Zhangjiang Night Dinner Reception (7:20 – 9:40 pm)

(Sponsored by the Zhangjiang National Biotech Pharmaceutical Base)

(College Hall, Montgomery County Community College)

· Presentation by the Zhangjiang Delegation to introduce the Shanghai Pudong New Area and the Zhangjiang National Biotech and Pharmaceutical Base

· Networking among speakers, attendees, sponsors, members of Chinese delegations

· Gourmet Italian buffet dinner (Served by Bon-Amico’s Catering, 610-539-8210)

· Live music band performance